🇺🇸 FDA
Patent

US 9624152

Hydroxyl compounds and compositions for cholesterol management and related uses

granted A61KA61K31/191A61K31/194

Quick answer

US patent 9624152 (Hydroxyl compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/191, A61K31/194, A61K31/20, A61K31/23